About Genome Canada
Genome Canada is a not-for-profit organization established by the Government of Canada in February 2000 with the mandate to develop and implement a national strategy for supporting large-scale genomics and proteomics research projects, for the benefit of all Canadians.
Genome Canada focuses its activities exclusively in the areas of genomics and proteomics research, with an emphasis on the delivery of tangible and measurable results. This approach has positioned Canada among the leaders in the following fields of expertise for genomics and proteomics research: human health, agriculture, environment, forestry, fisheries, and new technology development.
Additionally, Genome Canada continues to play a leadership role on the ethical, environmental, economic, legal and social issues (GE3LS) associated with genomics and proteomics research: since 2000, the Canadian federal government has invested $840 M in Genome Canada (as of 2010).
Funding structure and reporting
Projects and S&T platforms are selected based on their international competitiveness and scientific excellence in the framework of Canada's social and economic fabric. McGill is the host and major contributor to one of these platform services: the McGill University and Genome Quebec Innovation centre.
Genome Canada contributes up to 50% of the total cost of a project. Once a competition is launched, all applications are submitted via the corresponding Genome Centre of the Lead Project investigator: Genome Quebec, in our case. (Genome Quebec will generally also contribute from 25% to 35% of the total cost of the project.)
Genome Canada undertakes an interim review of each approved project and science and technology platform within approximately eighteen months from the start date. The interim review is one of the oversight methods used in Genome Canada-funded projects and platforms. For projects, it is used to evaluate the progress of the research including GE3LS.
2010 Large Scale Applied Research Project Competition: Competition for large scale research projects focusing on the application of genomics research such that there is a high potential for benefits to Canada to be realized or initiated before the end of the projects. Genome Canada will invest a maximum of $5M in a project representing 50% of the total funding per project.
Please consult the Genome Canada 2010 Guidelines[.pdf]
For other opportunities please check Genome Canada website or contact the OSR Institutional Strategic Initiatives (ISI) team.